Public Sector Pension Investment Board Acquires 4,779 Shares of Agilent Technologies, Inc. (NYSE:A)

Public Sector Pension Investment Board raised its holdings in Agilent Technologies, Inc. (NYSE:A) by 73.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,272 shares of the medical research company’s stock after buying an additional 4,779 shares during the period. Public Sector Pension Investment Board’s holdings in Agilent Technologies were worth $1,461,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the 4th quarter valued at about $26,000. Crewe Advisors LLC increased its position in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after acquiring an additional 101 shares during the period. Ridgewood Investments LLC acquired a new stake in Agilent Technologies in the 2nd quarter worth about $29,000. Rise Advisors LLC increased its holdings in shares of Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. acquired a new stake in shares of Agilent Technologies in the first quarter valued at approximately $34,000. Institutional investors own 87.42% of the company’s stock.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. The disclosure for this sale can be found here. Insiders have sold a total of 13,953 shares of company stock valued at $2,013,630 over the last 90 days. 0.33% of the stock is owned by insiders.

Agilent Technologies Trading Up 0.3 %

NYSE A opened at $148.48 on Tuesday. The company has a market cap of $43.32 billion, a price-to-earnings ratio of 35.10, a price-to-earnings-growth ratio of 6.48 and a beta of 1.05. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. The business’s fifty day moving average is $139.21 and its 200 day moving average is $139.01.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the firm posted $1.43 earnings per share. The business’s revenue for the quarter was down 5.6% on a year-over-year basis. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Evercore ISI increased their price objective on shares of Agilent Technologies from $130.00 to $135.00 and gave the stock an “in-line” rating in a research note on Thursday, August 22nd. TD Cowen raised their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Bank of America upped their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $142.93.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.